Cervical, Breast cancer
Conditions
Interventions
AI-aided US group:AI ultrasound assisted the doctor to complete the ultrasound examination
AI-unaided US group:The doctor completed the ultrasound examination without AI.
Regular HPV group:Regular HPV test
POCT group:HPV POCT test
Self sampling group:Women sampled themselves at home
Sponsors
Cancer Hospital, Chinese Academy of Medical Sciences
Eligibility
Sex/Gender
Female
Age
35 Years to 64 Years
Inclusion criteria
Inclusion criteria: (1) Breast cancer screening innovative technology: women aged 35-64 years; No visible signs of breast cancer; Ability to understand research procedures; Voluntary written informed consent. (2) Cervical cancer screening innovative technology: women aged 35-64 years; Have a sexual life, have an intact uterus, and have no visible signs of typical cervical cancer; Ability to understand research procedures; Voluntary written informed consent. (3) Cervical cancer screening is difficult to reach the population: women aged 35-64 years, sexual life, complete uterus, no visible signs of typical cervical cancer; Have not participated in cervical cancer screening in the past 10 years
Exclusion criteria
Exclusion criteria: (1) Breast cancer screening innovative technology: pregnant, lactating women or planning pregnancy; History of lumpectomy and breast augmentation; Those who have had a percutaneous breast piercing within one year; Previously diagnosed breast cancer patients. (2) Cervical cancer screening innovative technology: pregnancy; History of cervical therapy and pelvic radiation therapy; Patients with previously diagnosed cervical cancer. (3) Cervical cancer screening is difficult to reach the population: pregnancy; History of cervical therapy and pelvic radiation therapy; Patients with previously diagnosed cervical cancer.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity;Specificity;Positive and negative predictive values; | — |
Secondary
| Measure | Time frame |
|---|---|
| Detection rate of breast cancer;Vaginoscopy referral rate;CIN2 detection rate; | — |
Countries
China
Contacts
Public ContactFanghui Zhao
Cancer Hospital, Chinese Academy of Medical Sciences
Outcome results
None listed